Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker’s experimental mRNA bird-flu vaccine.
The funding from the Biomedical Advanced Research and Development Authority, an office within the U.S. Department of Health and Human Services, could total several tens of millions of dollars and include a commitment to purchase vaccine doses if the trial is successful, the Financial Times reported.
no FUCK YOU
deleted 0 points 11 months ago
deleted